Clinical trial
Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical…
NCT00300040 · Biopure Corporation, Industry · Terminated
Key facts
| NCT number | NCT00300040 |
|---|---|
| Title | Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia |
| Official title | Phase II, Multi-Center,Single-Blind,Placebo-Controlled Study,Evaluating Safety & Feasibility of HBOC-201 (Wound Healing Patients With Peripheral Vascular Disease & Undergoing Lower Limb Amputation Due to Critical Lower Limb Ischemia |
| Lead sponsor | Biopure Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | Hemoglobin glutamer 250 - bovine, 6% Hydroxyethylstarch |
| Enrollment | 16 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Mar 8, 2006 |
| Last update posted | May 16, 2008 |
| Countries | South Africa, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: